产前贝他他对胎儿心率的作用 短时间变化在生长受限制的胎儿中
Tjaša Šikonja1, Zala Sršen1, Ivan Verdenik2
1Faculty of Medicine, University of Ljubljana, Vrazov trg 2, 1000 Ljubljana, Slovenia.
Journal of perinatal medicine
|September 18, 2025
概括
产前甲最初会增加胎儿心率的短期变化 (STV) 在生长受限 (FGR) 和适合妊娠年龄 (AGA) 的胎儿中. 在FGR胎儿中,效果持续时间更长,在48小时后恢复到基线,而在AGA胎儿中则是24小时.
科学领域:
- 产科和妇科 产科和妇科
- 胎儿医学 胎儿医学
- 新生儿科学 新生儿科学
背景情况:
- 像贝他他这样的产前皮质类固醇对于胎儿肺部成熟至关重要.
- 胎儿生长限制 (FGR) 影响胎儿的福祉和对干预措施的反应.
- 胎儿心率的短期变化 (STV) 是胎儿神经状态的关键指标.
研究的目的:
- 为了比较产前贝他美沙对胎儿心率STV在FGR与AGA胎儿的影响.
- 为了确定贝塔梅他对STV的影响的持续时间,在这两个组.
- 评估与妊娠年龄和临床特征相关的STV变化.
主要方法:
- 卢布尔雅纳UMC的前性观察研究 (2023年6月至2024年6月).
- 包括21个FGR和20个AGA胎儿.
- 在甲给药前和给药后七天的连续STV测量.
- 使用线性回归和ANOVA进行统计分析.
主要成果:
- 在服用后6-12小时内,贝他在两组中都显著增加了STV (p < 0.001).
- 在FGR胎儿 (p=0.018) 中,STV升高持续了24小时,但在AGA胎儿中并非如此.
- 经过妊娠年龄调整,FGR胎儿始终显示STV低于AGA胎儿 (p=0.031).
结论:
- 产前贝他他会导致胎儿STV的暂时增加.
- 与AGA胎儿相比,FGR胎儿对贝他他有较长的STV反应.
- 需要进一步的研究来探索贝塔梅他在FGR怀孕中的延长效应.
相关概念视频
01:07Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
01:52Regression Toward the Mean
6.9K
Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.9K
01:31Adrenergic Antagonists: ɑ and β-Receptor Blockers
1.1K
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
1.1K